APA (7th ed.) Citation

Katagiri, J., Homma, J., Takagi, R., Sekine, H., Shinkawa, T., Niinami, H., & Shimizu, T. (2025). Intravenous mesenchymal stem cell transplantation mitigates pulmonary vascular remodeling but poses dose related risks in a pulmonary veno-occlusive disease model. Stem Cell Research & Therapy, 16(1), 1. https://doi.org/10.1186/s13287-025-04400-8

Chicago Style (17th ed.) Citation

Katagiri, Junko, Jun Homma, Ryo Takagi, Hidekazu Sekine, Takeshi Shinkawa, Hiroshi Niinami, and Tatsuya Shimizu. "Intravenous Mesenchymal Stem Cell Transplantation Mitigates Pulmonary Vascular Remodeling but Poses Dose Related Risks in a Pulmonary Veno-occlusive Disease Model." Stem Cell Research & Therapy 16, no. 1 (2025): 1. https://doi.org/10.1186/s13287-025-04400-8.

MLA (9th ed.) Citation

Katagiri, Junko, et al. "Intravenous Mesenchymal Stem Cell Transplantation Mitigates Pulmonary Vascular Remodeling but Poses Dose Related Risks in a Pulmonary Veno-occlusive Disease Model." Stem Cell Research & Therapy, vol. 16, no. 1, 2025, p. 1, https://doi.org/10.1186/s13287-025-04400-8.